大類學科： 不限 醫(yī)學 生物 物理 化學 農(nóng)林科學 數(shù)學 地學天文 地學 環(huán)境科學與生態(tài)學 綜合性期刊 管理科學 社會科學 查看全部熱門領域
投稿咨詢
ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas include but are not limited to:
Identification, synthesis, and optimization of lead biologically active molecules and drugs (small molecules and biologics)
Biological characterization of new molecular entities in the context of drug discovery
Computational, cheminformatics, and structural studies for the identification or SAR analysis of bioactive molecules, ligands and their targets, etc.
Novel and improved methodologies, including radiation biochemistry, with broad application to medicinal chemistry
Discovery technologies for biologically active molecules from both synthetic and natural (plant and other) sources
Pharmacokinetic/pharmacodynamic studies that address mechanisms underlying drug disposition and response
Pharmacogenetic and pharmacogenomic studies used to enhance drug design and the translation of medicinal chemistry into the clinic
Mechanistic drug metabolism and regulation of metabolic enzyme gene expression
Chemistry patents relevant to the medicinal chemistry field.
《Acs Medicinal Chemistry Letters》是一本由AMER CHEMICAL SOC出版商出版的專業(yè)醫(yī)學期刊，該刊創(chuàng)刊于2010年，刊期12 issues/year，該刊已被國際權威數(shù)據(jù)庫SCIE收錄。在中科院最新升級版分區(qū)表中，該刊分區(qū)信息為大類學科：醫(yī)學 3區(qū)，小類學科：藥物化學 3區(qū)；在JCR（Journal Citation Reports）分區(qū)等級為Q2。該刊發(fā)文范圍涵蓋藥物化學等領域，旨在及時、準確、全面地報道國內(nèi)外藥物化學工作者在該領域取得的最新研究成果、工作進展及學術動態(tài)、技術革新等，促進學術交流，鼓勵學術創(chuàng)新。2021年影響因子為4.632，平均審稿速度一般,3-8周。
| 大類學科 | 分區(qū) | 小類學科 | 分區(qū) | Top期刊 | 綜述期刊 |
| 醫(yī)學 | 3區(qū) | CHEMISTRY, MEDICINAL 藥物化學 | 2區(qū) | 否 | 否 |
| JCR分區(qū)等級 | JCR所屬學科 | 分區(qū) | 影響因子 |
| Q2 | CHEMISTRY, MEDICINAL | Q2 | 4.632 |
| 影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
| 4.632 | 52 | 9.70% | 100.00% | 未開放 | 一般,3-8周 |
課題、SCI/EI/SSCI怎么寫？